USANA Health Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Intangible Assets (Tables)

Intangible Assets (Tables)

12 Months Ended

Dec. 28, 2019

Intangible Assets [Abstract]

Schedule Of Goodwill


		December 28,			December 29,
		2019			2018
Balance at beginning of year:
Gross goodwill		$	16,815		$	17,417
Net goodwill as of beginning of year			16,815			17,417
Currency translation adjustment			(179)			(602)
Balance as of end of year
Gross goodwill			16,636			16,815
Net goodwill as of end of year		$	16,636		$	16,815

Schedule Of Finite And Indefinite Lived Intangible Assets


		As of December 28, 2019
												Weighted-average
		Gross carrying			Accumulated			Net carrying				amortization
		amount			amortization			amount				period (years)
Amortized intangible assets
Trade name and trademarks		$	3,791		$	(3,548)		$	243			10
Product formulas			8,360			(4,621)			3,739			8
Indefinite-lived intangible assets
Direct sales license			25,858						25,858
		$	38,009					$	29,840


Estimated Amortization Expense:
2020		$	1,278
2021			1,045
2022			1,045
2023			614
		$	3,982


		As of December 29, 2018
		Gross carrying ‎amount			Accumulated ‎amortization			Net carrying ‎amount			Weighted-average ‎amortization ‎period (years)
Amortized intangible assets
Trade name and trademarks		$	3,858		$	(3,226)		$	632			10
Product formulas			8,506			(3,637)			4,869			8
Indefinite-lived intangible assets
Direct sales license			26,310						26,310
		$	38,674					$	31,811